SCHEMBL7010158

SCHEMBL7010158

CCOc1nc2c(C)sc(C(=O)OC)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
RXFP1 Q9HBX9 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 3/20 0.38
MAPT P10636 4/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 1/20 0.36
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
HPGD P15428 5/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 3/20 0.33
TSHR P16473 2/20 0.33
NGFR P08138 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010160 0.89 KDM4E (0.39) KDM4ERXFP1NPC1RAB9ANPSR1
SCHEMBL7012347 0.77 CSNK2A2 (0.41) KDM4EKMT2AMAPTALDH1A1MEN1
SCHEMBL9031604 0.75 CSNK2A2 (0.40) NPSR1KMT2AMAPTALDH1A1MEN1
SCHEMBL9031779 0.75 CSNK2A2 (0.41) KDM4ERXFP1NPC1RAB9AKMT2A
SCHEMBL9031439 0.74 KDM4E (0.41) KDM4ENPC1RAB9AKMT2AMAPT
SCHEMBL9033546 0.74 TSHR (0.46) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL9033193 0.72 KMT2A (0.34) NPC1RAB9AKMT2AMAPTALDH1A1
SCHEMBL9032184 0.72 NGFR (0.34) KDM4ENPC1RAB9AKMT2AMAPT
SCHEMBL9031570 0.72 GPR84 (0.45) CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL9032276 0.71 HPGD (0.44) KDM4ERAB9AKMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed